Montelukast for kidney and heart health in young adults with type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests if montelukast, a common asthma medication, can help protect the kidneys and heart in adolescents and young adults with type 2 diabetes. It looks at how the drug affects markers of kidney function and blood vessel health over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 14 and 24 years old.
- You have been diagnosed with type 2 diabetes before age 18, and had it for less than 10 years.
- Your HbA1c (average blood sugar over 3 months) is less than 10%.
- Your blood pressure is below 130/80, or you're on a stable blood pressure medication for at least a month.
- Your body mass index (BMI) is under 40.
- You are not pregnant, planning pregnancy, or breastfeeding, and have no allergy to aspirin or shellfish.
- You are not currently using inhaled or steroid medications for asthma or other conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares different diabetes medicines to see which works best for people with type 2 diabetes who also have heart or blood vessel risks. It aims to find better treatment to protect your heart and kidneys.
This study follows young people with type 2 diabetes to better understand risks for kidney problems over time. It may help researchers find earlier warning signs and improve care for adolescents living with type 2 diabetes.
This study looks at how different foods affect kidney health in people with type 2 diabetes and early kidney disease. Researchers will compare dietary patterns across different ethnic groups to understand what helps protect kidneys.
This trial tests if montelukast, a common asthma medicine, can help protect the kidneys, heart, and eyes in people with type 2 diabetes. It is for those who already have some kidney damage (stage 2-3) and are taking certain blood pressure or diabetes medications.
This trial tests whether montelukast, a medicine commonly used for allergies, can improve kidney health and blood vessel function in adults with long-term type 1 diabetes. You may join a treatment group and have kidney and circulation measurements taken over the study period.
This Phase 4 trial studies an approach to help prevent heart problems in adults with type 2 diabetes who are at higher heart risk. It may help reduce future cardiovascular events by testing medications for safety and benefit in this group.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.